by TractManager | Dec 22, 2023 | Emerging Technology Report
Filsuvez (birch triterpenes) topical gel (formerly Oleogel-S10; Chiesi Global Rare Diseases) is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa in adult and pediatric patients 6 months of age and older.
by TractManager | Dec 21, 2023 | Emerging Technology Report
The Globe Pulsed Field Mapping and Ablation System is an investigational pulsed-field ablation system for treatment of atrial fibrillation.
by TractManager | Dec 20, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the EyeBOX test (Oculogica) as an aid in the diagnosis of concussion, also known as mild traumatic brain injury...
by TractManager | Dec 19, 2023 | Emerging Technology Report
The PulseSelect system (Medtronic Inc.) is a pulsed field ablation (PFA) system indicated for cardiac electrophysiological mapping (stimulation and recording) and for treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation or persistent...
by TractManager | Dec 11, 2023 | Emerging Technology Report
Lovotibeglogene autotemcel (Lyfgenia; Bluebird Bio Inc.) is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of patients 12 years of age or older with sickle cell disease and a history of vaso-occlusive events.
Recent Comments